Hermetica Superfood Encyclopedia
The Short Answer
Aniba rosaeodora essential oil is dominated by linalool (79–93.6%), a monoterpene alcohol that exerts antimicrobial, antifungal, antitrypanosomal, and antioxidant effects primarily through membrane disruption in microbial cells and free-radical scavenging. In vitro, the essential oil inhibits Trypanosoma cruzi epimastigotes with an IC50 of 150.5 µg/mL and scavenges ABTS radicals with an EC50 of 15.46 µg/mL, while cytotoxicity against mammalian macrophages remains low at CC50 greater than 1000 µg/mL.
CategoryHerb
GroupAmazonian
Evidence LevelPreliminary
Primary KeywordAniba rosaeodora benefits
Brazilian Rosewood — botanical close-up
Health Benefits
**Antioxidant Protection**
The essential oil scavenges ABTS radicals in a concentration-dependent manner with an EC50 of 15.46 µg/mL; isolated linalool achieves a superior EC50 of 6.78 µg/mL, indicating that linalool is the principal antioxidant driver.
**Antimicrobial Activity**
Linalool-rich oil inhibits Staphylococcus aureus and Escherichia coli at minimum inhibitory concentrations of 550–650 µg/mL, likely through disruption of bacterial cell membranes enabled by the compound's lipophilic character.
**Antifungal and Mycotoxin Suppression**
The essential oil inhibits Aspergillus flavus growth and aflatoxin B1 production at concentrations of 1.4 and 1.2 µl/mL respectively; nano-emulsified formulations reduce these thresholds further to 0.8 and 0.6 µl/mL, improving delivery efficiency.
**Antitrypanosomal Effects**
The oil demonstrates selective activity against Trypanosoma cruzi, the causative agent of Chagas disease, with IC50 values of 150.5 µg/mL against epimastigotes and 911.6 µg/mL against intracellular amastigotes, alongside a selectivity index greater than 1.0 relative to host macrophages.
**Anti-inflammatory Potential**: Linalool-containing chitosan membranes (0
5–5.0% w/w) incorporating 82.9% linalool oil have demonstrated reduced inflammatory markers in biocompatibility assays, attributed to cytokine pathway modulation by linalool.
**Sedative and Anxiolytic Properties (Traditional/Inferred)**: Linalool has been shown in preclinical rodent models across independent research to interact with GABAergic pathways and reduce locomotor activity, forming the mechanistic basis for A. rosaeodora's traditional use as a sedative and anticonvulsant in Amazonian ethnomedicine.
**Nanoformulation-Enhanced Bioavailability**
Encapsulation of the essential oil in nanoemulsions at loading levels of 0.38–2.48% achieves encapsulation efficiencies of 70–95%, meaningfully improving controlled release and antifungal potency compared to unformulated oil.
Origin & History
Natural habitat
Aniba rosaeodora is a slow-growing aromatic tree native to the tropical rainforests of the Amazon Basin, distributed across Brazil, Peru, Colombia, and French Guiana, thriving in humid lowland environments below 500 meters elevation. The species has been harvested extensively since the early twentieth century for its heartwood and leaves, from which a linalool-rich essential oil is steam-distilled and traded globally as 'rosewood oil' in the fragrance and cosmetics industries. Overharvesting has rendered wild populations critically threatened, prompting Brazilian regulatory protections and renewed interest in sustainable leaf-based distillation and plantation cultivation.
“Aniba rosaeodora has been harvested in the Brazilian Amazon since at least the early 1900s, when rosewood oil distillation became a major regional industry supplying the global perfumery trade, most famously as a fixative ingredient in Chanel No. 5. Indigenous and caboclo communities of the Amazon Basin incorporated the aromatic wood and oil into traditional healing practices, attributing sedative, anticonvulsant, and antidepressant properties to its use, likely mediated by linalool's neurological effects observed in subsequent pharmacological research. The species became so heavily exploited for its high-value heartwood oil that it was designated as endangered under Brazilian environmental law, and IBAMA (Brazil's environmental agency) imposed strict harvest quotas beginning in the 1990s, accelerating research into leaf-based distillation as a sustainable alternative. The plant holds cultural significance both as a symbol of Amazonian ecological loss and as a continuing subject of bioprospecting interest for its antimicrobial and antiparasitic potential against neglected tropical diseases like Chagas disease.”Traditional Medicine
Scientific Research
The available evidence base for Aniba rosaeodora consists exclusively of in vitro laboratory studies; no animal pharmacological trials or human clinical trials have been published in accessible peer-reviewed literature. Studies have characterized the essential oil's chemical composition via GC-MS and assessed antimicrobial MICs, antitrypanosomal IC50 values, and antioxidant EC50 values from small experimental replicates (typically n=3–6 per assay), which limits statistical confidence and generalizability. A key antifungal study demonstrated complete inhibition of Aspergillus flavus and aflatoxin B1 production at sub-2 µl/mL concentrations, and a nanoemulsion formulation study systematically evaluated encapsulation efficiency across multiple oil-to-surfactant ratios. The totality of evidence is preliminary and mechanistically inferential, with most bioactivity attributable to linalool chemistry extrapolated from broader terpene literature rather than confirmed through trials using A. rosaeodora as the test substance.
Preparation & Dosage
Traditional preparation
**Steam-Distilled Essential Oil (Neat)**
No clinically validated human dose established; traditionally applied topically or inhaled aromatically; research assays use concentrations of 150–1000 µg/mL in vitro, which do not translate directly to human dosing.
**Ethanol-Diluted Solution**
The essential oil is soluble 1:2 in 70% ethanol, a common preparation form used in laboratory studies and traditional dispensing; no standardized therapeutic dose defined.
**Nanoemulsion (Investigational)**
Formulated at oil-loading levels of 0.38–2.48% with encapsulation efficiencies of 70–95% for controlled antifungal applications; strictly experimental and not commercially available as a supplement.
**Chitosan Membrane (Topical/Wound Application)**
Used at 0.5–5.0% w/w essential oil incorporation in biomedical materials research for anti-inflammatory and antimicrobial wound dressings; not a consumer supplement form.
**Standardization**
No official pharmacopoeial standardization exists; research-grade oils are characterized by GC-MS with linalool content of 79–93.6% as the primary quality marker.
**Traditional Preparation**
Amazonian healers traditionally steam-distilled wood and bark to produce medicinal oil, used in small topical or inhaled amounts; exact ethnobotanical dosing is undocumented in the formal literature.
Nutritional Profile
Aniba rosaeodora is not consumed as a food ingredient and possesses no conventional macronutrient or micronutrient profile of dietary significance. Its pharmacological value resides entirely in its volatile essential oil fraction, which contains linalool as the dominant phytochemical (79–93.6%), with minor constituents including α-terpinolene (up to 3.37%), linalool cis-oxide (up to 3.03%), β-selinene (up to 2.0%), aromadendrene oxide (up to 2.5%), (E)-nerolidyl acetate (up to 1.5%), and cis-linalool oxide (up to 1.84%). Linalool is a lipophilic monoterpene alcohol with a logP of approximately 2.97, conferring good membrane permeability but rapid hepatic first-pass metabolism that limits oral bioavailability of intact linalool; inhalation and topical routes are considered more pharmacokinetically favorable. No vitamins, minerals, proteins, or dietary fibers of nutritional consequence have been identified in the essential oil fraction.
How It Works
Mechanism of Action
Linalool, which constitutes up to 93.6% of A. rosaeodora essential oil, exerts its antimicrobial effects by intercalating into microbial phospholipid bilayers due to its lipophilic terpene structure, increasing membrane permeability, dissipating proton gradients, and ultimately causing cell lysis at concentrations in the range of 550–650 µg/mL. Its antioxidant activity involves direct hydrogen atom transfer to ABTS and DPPH radical species, with an electron-donating hydroxyl group on the linalool molecule serving as the reactive moiety, achieving EC50 values as low as 6.78 µg/mL for isolated linalool. Sedative and anticonvulsant actions attributed to the plant in traditional contexts are mechanistically supported by linalool's documented positive modulation of GABA-A receptors and inhibition of glutamate-mediated excitotoxicity in neuronal preparations, though these studies have been conducted on purified linalool rather than on A. rosaeodora oil or plant extracts directly. Anti-inflammatory effects likely involve downregulation of pro-inflammatory cytokines such as TNF-α and IL-6 via NF-κB pathway inhibition, a mechanism established for linalool in cell-based models but not yet confirmed in studies using A. rosaeodora preparations specifically.
Clinical Evidence
No human clinical trials or controlled animal intervention studies have been conducted on Aniba rosaeodora or its essential oil as of the available research record. All quantified efficacy data derive from in vitro assays measuring IC50, MIC, EC50, and CC50 endpoints in microbial, parasitic, or cell culture models, with effect sizes that are pharmacologically interesting but of unknown translational relevance to human physiology. The antitrypanosomal selectivity index exceeding 4.0 for isolated linalool versus macrophages is a noteworthy preclinical safety signal, but dose-response relationships in living organisms remain uninvestigated. Confidence in clinical applicability is therefore very low, and the ingredient should be regarded as a candidate for future pharmacological investigation rather than an evidence-supported therapeutic agent.
Safety & Interactions
In vitro cytotoxicity studies indicate that A. rosaeodora essential oil and isolated linalool are non-cytotoxic to mammalian macrophages up to CC50 values exceeding 1000 µg/mL, suggesting an acceptable safety margin at concentrations needed for antimicrobial or antiparasitic effects, though these findings cannot be directly extrapolated to human systemic exposure. No drug interaction data exist for A. rosaeodora specifically; however, linalool's documented GABAergic activity raises theoretical concern for additive central nervous system depression when combined with benzodiazepines, barbiturates, alcohol, or other sedative agents, warranting caution until formal interaction studies are performed. No human adverse event reports, contraindications, or maximum safe dose thresholds have been established in the clinical literature, and the ingredient is entirely absent from major pharmacopoeial safety monographs. Use during pregnancy or lactation is not supported by any safety data and should be avoided; individuals with known monoterpene or fragrance allergies may experience contact sensitization with topical application of the essential oil.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Pau-rosaRosewood oil plantBrazilian Rosewood (Aniba rosaeodora)Aniba rosaeodora DuckeBrazilian rosewoodAmazonian rosewood
Frequently Asked Questions
What is Aniba rosaeodora used for medicinally?
Aniba rosaeodora is traditionally used in Amazonian ethnomedicine as a sedative, anticonvulsant, and antidepressant, properties attributed to linalool, which constitutes up to 93.6% of its essential oil. In modern research, the oil has demonstrated in vitro antimicrobial activity against Staphylococcus aureus and E. coli (MIC 550–650 µg/mL), antifungal effects against Aspergillus flavus, and antitrypanosomal activity against Trypanosoma cruzi with an IC50 of 150.5 µg/mL; however, no human clinical trials have been conducted to validate these effects.
Is Brazilian rosewood essential oil safe to use?
In vitro safety testing shows that A. rosaeodora essential oil has low cytotoxicity against mammalian macrophages, with a CC50 exceeding 1000 µg/mL, meaning it does not significantly harm host cells at the concentrations needed for antimicrobial effects. However, no human safety studies, established maximum doses, or long-term toxicity data exist, and individuals with fragrance or monoterpene allergies may experience skin sensitization; use during pregnancy or lactation should be avoided due to the complete absence of safety data in those populations.
How much linalool does Aniba rosaeodora essential oil contain?
Aniba rosaeodora essential oil contains linalool as its overwhelmingly dominant compound, with concentrations ranging from 79.0% to 93.6% depending on geographic origin, plant part distilled, and chemotype; one well-characterized Brazilian sample showed 93.60% linalool with minor components including α-terpinolene (3.37%) and linalool cis-oxide (3.03%). Minor chemotypic variants with lower linalool fractions around 39.6% have been reported but are atypical of Amazonian commercial samples.
Does Aniba rosaeodora help with Chagas disease?
In vitro research shows that A. rosaeodora essential oil inhibits Trypanosoma cruzi epimastigotes with an IC50 of 150.5 µg/mL and intracellular amastigotes with an IC50 of 911.6 µg/mL, while isolated linalool achieves IC50 values of 198.6 µg/mL and 249.6 µg/mL respectively, with a selectivity index greater than 4.0 against host macrophages. These findings are scientifically interesting for neglected tropical disease research but remain strictly preclinical; no animal models or human trials have evaluated A. rosaeodora for Chagas disease treatment.
Why is Brazilian rosewood endangered and can it be sustainably sourced?
Aniba rosaeodora was heavily overexploited throughout the twentieth century for its aromatic heartwood, which was felled and steam-distilled to produce rosewood oil for the global perfumery industry, drastically depleting wild populations across the Amazon Basin. Brazilian environmental authorities imposed strict harvest regulations through IBAMA, and sustainable alternatives including leaf-based distillation from managed plantations are now being developed, as the leaves also yield linalool-rich oil without requiring the tree to be destroyed.
How does linalool in Brazilian rosewood oil compare to linalool from other sources for antioxidant protection?
Linalool isolated from Aniba rosaeodora demonstrates superior antioxidant potency with an EC50 of 6.78 µg/mL against ABTS radicals, outperforming the whole essential oil (EC50 15.46 µg/mL). While linalool is found in many plants like lavender and basil, the high concentration and purity of linalool in Brazilian rosewood oil makes it a particularly efficient source for antioxidant benefits. This concentration-dependent activity suggests that the bioavailability and extraction method of the source plant significantly impacts antioxidant efficacy.
What does research show about Brazilian rosewood oil's effectiveness against bacterial infections?
Clinical and in vitro research demonstrates that the linalool-rich essential oil from Aniba rosaeodora inhibits common pathogenic bacteria including Staphylococcus aureus and Escherichia coli at minimum inhibitory concentrations of 550 µg/mL. These findings suggest potential antimicrobial applications, though most evidence is laboratory-based rather than from human clinical trials. Further research is needed to establish effective dosing and delivery methods for therapeutic use in humans.
Is Brazilian rosewood essential oil suitable for use in topical skincare products, and at what concentrations?
Brazilian rosewood essential oil's documented antioxidant and antimicrobial properties make it a candidate for skincare formulations aimed at protecting against bacterial growth and oxidative stress. The concentration of linalool (typically 75-95% of the oil) is the key driver of these benefits; however, essential oils require proper dilution in carrier oils before topical application to prevent skin irritation. Optimal concentrations for skincare use should be determined based on product type and individual skin sensitivity, though specific dermatological studies on Brazilian rosewood oil in cosmetic formulations remain limited.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w aniba-rosaeodora-brazilian-rosewood curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
